Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
20
SHYG Quote, Financials, Valuation and Earnings
Last price:
$42.87
Seasonality move
:
0.15%
Day range:
$42.79 - $42.88
52-week range:
$40.38 - $43.39
Dividend yield:
7.04%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
1.9M
Avg. volume:
1.6M
1-year change:
0.63%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, iShares 0-5 Year High Yield Corporate Bond ETF has -- downside to fair value with a price target of -- per share.
SHYG vs. S&P 500
-
Over the past 5 trading days, iShares 0-5 Year High Yield Corporate Bond ETF has underperformed the S&P 500 by -1.73% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
iShares 0-5 Year High Yield Corporate Bond ETF does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
iShares 0-5 Year High Yield Corporate Bond ETF has grown year-over-year revenues for 0 quarters straight. In the most recent quarter iShares 0-5 Year High Yield Corporate Bond ETF reported revenues of --.
Earnings Growth
-
iShares 0-5 Year High Yield Corporate Bond ETF has grown year-over-year earnings for 0 quarters straight. In the most recent quarter iShares 0-5 Year High Yield Corporate Bond ETF reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-25 | 2024-12-25 | 2024-12-25 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2021-12-25 | 2022-12-25 | 2023-12-25 | 2024-12-25 | ||
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | -- | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-25 | 2024-12-25 | 2024-12-25 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
SHYG
Sector
Market Cap
--
--
Price % of 52-Week High
98.59%
--
Dividend Yield
7.04%
--
Shareholder Yield
--
--
1-Year Price Total Return
0.66%
--
Beta (5-Year)
0.609
--
Dividend yield:
7.04%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$42.87
200-day SMA
Buy
Level
$42.75
Bollinger Bands (100)
Sell
Level
42.82 - 43.18
Chaikin Money Flow
Buy
Level
1.4M
20-day SMA
Sell
Level
$42.90
Relative Strength Index (RSI14)
Sell
Level
49.20
ADX Line
Sell
Level
17.85
Williams %R
Neutral
Level
-75.8621
50-day SMA
Sell
Level
$42.91
MACD (12, 26)
Buy
Level
10.57
25-day Aroon Oscillator
Buy
Level
28
On Balance Volume
Neutral
Level
598.9K
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Stock Forecast FAQ
In the current month, SHYG has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SHYG average analyst price target in the past 3 months is --.
-
Where Will iShares 0-5 Year High Yield Corporate Bond ETF Stock Be In 1 Year?
According to analysts, the consensus estimate is that iShares 0-5 Year High Yield Corporate Bond ETF share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About iShares 0-5 Year High Yield Corporate Bond ETF?
Analysts are divided on their view about iShares 0-5 Year High Yield Corporate Bond ETF share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that iShares 0-5 Year High Yield Corporate Bond ETF is a Sell and believe this share price will rise from its current level to --.
-
What Is iShares 0-5 Year High Yield Corporate Bond ETF's Price Target?
The price target for iShares 0-5 Year High Yield Corporate Bond ETF over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SHYG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for iShares 0-5 Year High Yield Corporate Bond ETF is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of SHYG?
You can purchase shares of iShares 0-5 Year High Yield Corporate Bond ETF via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase iShares 0-5 Year High Yield Corporate Bond ETF shares.
-
What Is The iShares 0-5 Year High Yield Corporate Bond ETF Share Price Today?
iShares 0-5 Year High Yield Corporate Bond ETF was last trading at $42.87 per share. This represents the most recent stock quote for iShares 0-5 Year High Yield Corporate Bond ETF. Yesterday, iShares 0-5 Year High Yield Corporate Bond ETF closed at $42.86 per share.
-
How To Buy iShares 0-5 Year High Yield Corporate Bond ETF Stock Online?
In order to purchase iShares 0-5 Year High Yield Corporate Bond ETF stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get SHYG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SHYG
Sector
P/E ratio
--
--
PEG ratio
--
--
P/B ratio
--
--
Price / LTM sales
--
--
Growth Metrics
SHYG
Sector
Revenue growth
--
--
Earnings growth
--
--
Revenue (5-year growth)
--
--
Earnings forecast
--
--
Profitability
SHYG
Sector
Profitability FY 2025
--
--
Return on invested capital
--
--
Return on assets
--
--
Return on equity
--
--
Earnings Date
Last Earnings Date
Dec
25
Next Earnings Date
Dec
25
Estimated Next Earnings Date
Mar
26
Balance Sheet
SHYG
Sector
Total cash
--
--
Short term investments
--
--
Total assets
--
--
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
